Stephen T. Baker
Corporate Officer/Principal bei Tatum CFO Partners LLP
Profil
Stephen T.
Baker is currently a Partner at Tatum CFO Partners LLP since 2013.
He was previously the Chief Financial Officer at Mercator MedSystems, Inc. and the CFO & Principal Financial & Accounting Officer at WaferGen Bio-systems, Inc. in 2014.
He holds an MBA from The Trustees of Columbia University in The City of New York and an undergraduate degree from the University of Pennsylvania.
Aktive Positionen von Stephen T. Baker
| Unternehmen | Position | Beginn |
|---|---|---|
| Tatum CFO Partners LLP | Corporate Officer/Principal | 01.01.2013 |
Ehemalige bekannte Positionen von Stephen T. Baker
| Unternehmen | Position | Ende |
|---|---|---|
Mercator MedSystems, Inc.
 Mercator MedSystems, Inc. Medical SpecialtiesHealth Technology Mercator MedSystems, Inc. develops medical injection devices. The firm focuses on the treatment of peripheral artery disease using its catheter-guided, micro-infusion systems for site-specific, non-systemic delivery of therapeutic agents directly across any blood vessel. It offers bullfrog micro-infusion device and blowfish trans-bronchial micro-infusion device. The company was founded by Kirk Patrick Seward, Michael Vestel, and Albert P. Pisano in 2000 and is headquartered in Emeryville, CA. | Finanzdirektor/CFO | - |
| WAFERGEN BIO-SYSTEMS, INC. | Finanzdirektor/CFO | 16.04.2014 |
Ausbildung von Stephen T. Baker
| University of Pennsylvania | Undergraduate Degree |
| The Trustees of Columbia University in The City of New York | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
WaferGen Bio-systems, Inc.
 WaferGen Bio-systems, Inc. BiotechnologyHealth Technology WaferGen Bio-systems, Inc. used to provide genomic technology solutions for single-cell analysis and clinical research. The firm offered SmartChip Real-Time polymerase chain reaction (PCR) system, which provided a suite of gene expression and genome analysis technologies enabling biomarker discovery and validation on a single platform with the sensitivity and accuracy of PCR. The company was founded by Alnoor Shivji, Victor Joseph and Amjad Huda on October 22, 2002 and was headquartered in Fremont, CA. | Health Technology |
| Tatum CFO Partners LLP | |
Mercator MedSystems, Inc.
Mercator MedSystems, Inc. Medical SpecialtiesHealth Technology Mercator MedSystems, Inc. develops medical injection devices. The firm focuses on the treatment of peripheral artery disease using its catheter-guided, micro-infusion systems for site-specific, non-systemic delivery of therapeutic agents directly across any blood vessel. It offers bullfrog micro-infusion device and blowfish trans-bronchial micro-infusion device. The company was founded by Kirk Patrick Seward, Michael Vestel, and Albert P. Pisano in 2000 and is headquartered in Emeryville, CA. | Health Technology |
